US Patent 11771733 Lisinopril formulations
Patent 11771733 was granted and assigned to Silvergate Pharmaceuticals, Inc. on October, 2023 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 11771733 Lisinopril formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.